Register now!

Your details

Privacy policy

Date and time

Wednesday
30
September
17:00 CEST
Confirm sign-up

Fibroblast Activity and Tissue Destruction in Rheumatology: Understanding Tissue Activity and Its Implications for Drug Development 

Fibrogenesis, fibroblast activity and tissue destruction and its relevance in autoimmunity, PsA, RA, SSc and lupus 

The body continuously regenerates, which inherently means that tissue is constantly being broken down and formed. In rheumatic diseases we usually focus on inflammation and immune activity, but inflammation is what starts the process, not what causes the lasting harm. The damage comes when that balance tips, fibroblasts become activated, and cartilage, bone, and connective tissue are broken down faster than the body can repair them.
​​​​​​​
Join us to explore how evaluating tissue activity reveals what is actively happening in the disease biology, whether a treatment is truly working, and how these insights can support the development of better therapies in autoimmunity, PsA, RA, SSc and lupus. 

Learn more
Format
60-70 minutes presentation followed by 20-30 minutes of audience Q&A.

Agenda
- Welcome and introduction
- Fibroid and synovial pathotypes in rheumatoid arthritis
- Tissue destruction and regulation of fibrogenesis in rheumatology
- And more!
- Questions from the chat 

Speakers
Coming soon!

Expected duration
90 minutes


Share this webinar